Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors
Clinical trial NCT05905614 · COMPLETED
Trial details
- NCT number
- NCT05905614
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-03
- Primary completion
- 2023-10-26
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.